FDA panel votes to add peptides to permitted compounding list despite opposition from agency scientists
On Thursday, the Food and Drug Administration's (FDA) committee on compounded drugs broke with agency scientists and voted in favor of adding peptides to the list of substances compounding pharmacies can make, despite concerns being raised over the lack of demonstrated benefits.
The FDA's Pharmacy Compounding Advisory Committee (PCAC) heard public comments and saw presentations by agency staffers concerning the peptides BPC-157, KPV, TB-500 and MOTS-c.
These...
이 뉴스, 어떠셨어요?
탭 한 번으로 반응 · 로그인 불필요
공식 발표 ↔ 진영별 보도
FDA advisory panel recommends loosening restrictions on 2 unapproved peptides
FDA panel recommends easing restrictions on several peptides, including BPC-157
FDA panel recommends controversial treatments
US health panel recommends easing restrictions on controversial peptides
+6
FDA panel votes to add peptides to permitted compounding list despite opposition from agency scientists
WATCH LIVE: Day 2 of FDA advisory panel meeting to consider use of peptides
An FDA Panel Just Endorsed These Unproven Peptides
FDA panel loosens restrictions for controversial peptides popular online
+8